|
'Pathway Search Results'
- Selection criteria for significant gene list :
-
Significant genes are selected with a p value cut-off of 0.1. The resultant list was then sorted in a descending order of fold change value. From the sorted list, the top 100 genes were selected for pathway/network. If the gene list is less than 100, the entire gene list was taken for pathway/network analysis.
|
>>Total hits : 8
, Search term given : Duchenne AND Muscular AND Dystrophy
|
Duchenne muscular dystrophy (HG-U95C)
|
GEO Description :
Examination of muscle biopsies from Duchenne muscular dystrophy patients and normal subjects of various age groups. Both mixed groups of patients (5 patient biopsies per group) and individual biopsies analyzed.
Organism : Homo sapiens
GEO-ID : GDS263
|
|
|
- Compared Group :
- normal Vs Duchenne muscular dystrophy
|
- Number of Nodes in the Network : 25
- Number of Nodes passing Cut-Off : 99
- PValue Cut-Off : 1.71967167261755e-05
- Fold Change Cut-Off : 3.61
|
Duchenne muscular dystrophy (HG-U95D)
|
GEO Description :
Examination of muscle biopsies from Duchenne muscular dystrophy patients and normal subjects of various age groups. Both mixed groups of patients (5 patient biopsies per group) and individual biopsies analyzed.
Organism : Homo sapiens
GEO-ID : GDS264
|
|
|
- Compared Group :
- normal Vs Duchenne muscular dystrophy
|
- Number of Nodes in the Network : 30
- Number of Nodes passing Cut-Off : 99
- PValue Cut-Off : 1.19502910820302e-05
- Fold Change Cut-Off : 2.44
|
Utrophin/dystrophin-deficient double mutant and dystrophin-deficient mdx mutant skeletal muscles
|
GEO Description :
Comparison of skeletal muscles of utrophin/dystrophin double knockout (dko) mutants and dystrophin-deficient mdx mutants. dko and mdx mutants display skeletal muscle weakness and degeneration but only dko mutants display clinical features similar to Duchenne muscular dystrophy patients.
Organism : Mus musculus
GEO-ID : GDS2001
|
|
|
- Compared Group :
- dko Vs mdx
|
- Number of Nodes in the Network : 24
- Number of Nodes passing Cut-Off : 100
- PValue Cut-Off : 0.000881270738318563
- Fold Change Cut-Off : 2.01
|
|
|
- Compared Group :
- heart Vs leg
|
- Number of Nodes in the Network : 34
- Number of Nodes passing Cut-Off : 100
- PValue Cut-Off : 4.17234996552551e-11
- Fold Change Cut-Off : 2.03
|
|
|
- Compared Group :
- heart Vs extraocular
|
- Number of Nodes in the Network : 26
- Number of Nodes passing Cut-Off : 100
- PValue Cut-Off : 1.00541595882131e-10
- Fold Change Cut-Off : 2.06
|
|
|
- Compared Group :
- leg Vs extraocular
|
- Number of Nodes in the Network : 40
- Number of Nodes passing Cut-Off : 100
- PValue Cut-Off : 1.39091902440214e-08
- Fold Change Cut-Off : 2.1
|
Various muscle diseases (HG-U133B)
|
GEO Description :
Analysis of muscle biopsy specimens from patients with various muscle diseases. Results provide insight into the diagnosis and pathogenesis of muscle diseases.
Organism : Homo sapiens
GEO-ID : GDS2855
|
|
|
- Compared Group :
- normal Vs Duchenne muscular dystrophy
|
- Number of Nodes in the Network : 10
- Number of Nodes passing Cut-Off : 100
- PValue Cut-Off : 1.28204100113827e-10
- Fold Change Cut-Off : 2.82
|
Various muscle diseases (HG-U133A)
|
GEO Description :
Analysis of muscle biopsy specimens from patients with various muscle diseases. Results provide insight into the diagnosis and pathogenesis of muscle diseases.
Organism : Homo sapiens
GEO-ID : GDS1956
|
|
|
- Compared Group :
- normal Vs Duchenne muscular dystrophy
|
- Number of Nodes in the Network : 47
- Number of Nodes passing Cut-Off : 100
- PValue Cut-Off : 3.90723090148387e-16
- Fold Change Cut-Off : 2.17
|
DISCLAIMER:
The interactions, networks, list of genes/molecules or any other information presented here, is HYPOTHETICAL in nature and is based on information collected from public as well as other sources, and is analyzed by certain automated mining and analysis software workflows. Strandlife Science Pvt.Ltd. or the Editors of PathwayWorld offer this information with NO CLAIMS of accuracy and WARRANTIES of any kind, and DO NOT Accept liability or legal responsibility for losses allegedly caused by using this information.
GeneSpring® is a registered trademark of Agilent Technologies.
GeneSpring® is developed on AVADIS™ from Strand Life Sciences
|
